Is BPC-157 Legal in 2026? What the FDA Vote Actually Changed
October 6, 2026 · 5 min read · Clinically reviewed
What happened
In April 2026 the FDA removed BPC-157 and several other peptides from its list of substances with significant safety concerns. In July 2026, the FDA's Pharmacy Compounding Advisory Committee narrowly voted to recommend adding BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon to the list of substances pharmacies can compound.
What it didn't change
The committee's vote is a recommendation. The FDA still has to make it official through rulemaking, and there's no deadline for that. Until it does, licensed pharmacies can't legally compound these peptides, and none of them are FDA-approved drugs.
BPC-157 and TB-500 are also banned in drug-tested sports.
Why Apex Method is waiting
We only prescribe FDA-approved medicines, and we'd rather tell you 'not yet' than sell you something from a gray-market source. When the FDA formally lists these peptides, we'll evaluate them with the same standard we use for everything else.